Telehealth Ledger

FDA warning letters

Published by Telehealth LedgerSource checked 25 October 2026

As of 25 October 2026, five commission-earning providers have an FDA warning letter in Telehealth Ledger's regulatory records.

A warning letter is FDA's allegation, not a court finding; closeout status as published by FDA.

Commission-earning catalog providers with an FDA warning letter in Telehealth Ledger’s regulatory records. Letter pages opened 25 October 2026.
EntityLetter dateSubjectLetter
Eden Health International Inc. dba Eden8 June 2026False & Misleading Claims/Misbranded (Telehealth)fda.gov
Lean Rx, Inc. dba SkinnyRx20 February 2026False & Misleading Claims/Misbranded (Telehealth)fda.gov
Strut Health, LLC dba Strut20 February 2026False & Misleading Claims/Misbranded (Telehealth)fda.gov
directmeds.com, Inc. dba DirectMeds9 September 2025Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)fda.gov
Sprout Health Partners LLC dba Sprout Health9 September 2025Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)fda.gov

Questions

Which commission-earning providers have an FDA warning letter?
As of 25 October 2026, the records name Eden Health International Inc. dba Eden (8 June 2026), Lean Rx, Inc. dba SkinnyRx (20 February 2026), Strut Health, LLC dba Strut (20 February 2026), directmeds.com, Inc. dba DirectMeds (9 September 2025), and Sprout Health Partners LLC dba Sprout Health (9 September 2025). Each name is the recipient line on the FDA letter.
Is an FDA warning letter a court finding?
A warning letter is FDA's allegation, not a court finding; closeout status as published by FDA. The letter pages opened on 25 October 2026 do not publish a close-out.
Does this page list every FDA warning letter?
No. The table includes a commission-earning catalog provider only when Telehealth Ledger's regulatory records already contain an FDA warning letter for that provider. A name that is absent is not a finding that FDA has no record.

The name in the table is the recipient line on the FDA letter. The catalog profile uses the provider name on this site.

Sources

Each letter page below was opened on the date shown. The subject is the description on that page.

  1. Eden Health International Inc. dba Eden: False & Misleading Claims/Misbranded (Telehealth) · checked 25 October 2026
  2. Lean Rx, Inc. dba SkinnyRx: False & Misleading Claims/Misbranded (Telehealth) · checked 25 October 2026
  3. Strut Health, LLC dba Strut: False & Misleading Claims/Misbranded (Telehealth) · checked 25 October 2026
  4. directmeds.com, Inc. dba DirectMeds: Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth) · checked 25 October 2026
  5. Sprout Health Partners LLC dba Sprout Health: Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth) · checked 25 October 2026